Key Agenda Items Approved

1. Material Related Party Transactions
  • Approved material related party transactions totaling ₹330 crore for financial year 2026-27
  • Requires shareholder approval in ensuing Annual General Meeting
  • Transactions considered "material" as they exceed ₹1,000 crore or 10% of annual consolidated turnover (whichever lower)
  • Detailed transactions:
  • Agri One India Ventures LLP (Promoter): ₹40 crores
  • UG Patwardhan Services Private Limited (Promoter): ₹40 crores
  • Kaushal Uttam Shah (Promoter): ₹40 crores
  • GTT Data Solutions Limited (Same Promoter Group): ₹40 crores
  • SMCV Management Services Private Limited (Same Promoter Group): ₹50 crores
  • Health Secure Hospitals Private Limited (Wholly owned subsidiary): ₹40 crores
  • Arvaya Healthtech & Wellness Private Limited (Wholly owned subsidiary): ₹40 crores
  • Sushodha Institute of Gastroenterology Private Limited (Related Party): ₹40 crores
2. Appointment of Company Secretary for Subsidiary
  • Approved appointment of CS Guinea Agrawal as Company Secretary and Key Managerial Personnel of Arvaya Healthtech & Wellness Private Limited (wholly owned subsidiary)
  • Appointment permitted under Section 203(3) of Companies Act, 2013 as it's a wholly owned subsidiary
3. Appointment of Additional Director for Subsidiaries
  • Approved appointment of Mr. Rahul Ravindra Mayur (DIN:09203474) as Additional Non-Executive Independent Director on boards of:

(i) Arvaya Healthtech & Wellness Private Limited

(ii) Health Secure Hospitals Private Limited

(iii) Tec-Pool Solutions Private Limited

  • Compliance with Regulation 24(1) of Listing Regulations requiring independent director on material subsidiary boards
4. Financial Results for Q1 FY27
  • Approved unaudited standalone and consolidated financial results for quarter ended June 30, 2026
  • Prepared in accordance with Regulation 33 of SEBI Listing Regulations
  • Results uploaded on company website: https://www.arvayahealth.com/

Standalone Financial Results (₹ in Lacs):

  • Revenue from operations: 10.00
  • Other income: 6.17
  • Total Income: 16.17
  • Total Expenses: 104.73
  • Employee benefits expense: 79.20
  • Finance costs: 14.39
  • Other expenses: 11.15
  • Profit before tax: (88.57)
  • Profit for the period: (88.57)
  • Total Comprehensive Income: (88.57)
  • Paid Up Equity Share Capital: 4,802.19
  • Face Value per share: ₹10.00
  • Basic EPS: (0.18)
  • Diluted EPS: (0.18)

Consolidated Financial Results (₹ in Lacs):

  • Revenue from operations: 3,009.57
  • Other income: 6.17
  • Total Income: 3,015.74
  • Total Expenses: 2,953.62
  • Profit before tax: 55.95
  • Tax expense: 2.72
  • Profit for the period: 53.23
  • Total Comprehensive Income: 54.87
  • Attributable to owners of parent: 39.94
  • Attributable to non-controlling interests: 14.93
  • Paid Up Equity Share Capital: 4,802.19
  • Face Value per share: ₹10.00
  • Basic EPS: 0.08
  • Diluted EPS: 0.08
5. Annual Secretarial Compliance Report
  • Took note of Annual Secretarial Compliance Report for FY 2025-26 issued by M/s. SKGK & Associates, LLP
  • Prepared in accordance with Regulation 24A of SEBI Listing Regulations
6. Secretarial Audit Report
  • Took note of Secretarial Audit Report in Form MR-3 for FY 2025-26 issued by M/s. SKGK & Associates, LLP
  • Prepared pursuant to Section 204 of Companies Act, 2013
7. Annual General Meeting
  • Approved convening of 41st Annual General Meeting on Monday, September 21, 2026
  • In accordance with Section 96 of Companies Act, 2013
8. Scrutinizer Appointment
  • Appointed Mr. Chinmay Mohan Lele (Practicing Company Secretary) as scrutinizer for e-voting process
  • For ensuing Annual General Meeting pursuant to Section 108 of Companies Act, 2013
9. Nomination and Remuneration Committee Reconstitution
  • Reconstituted committee by inducting Ms. Manali Pandit (Non-Executive Independent Director, DIN:11495478)
  • Replacing Mr. Salil Shetty (CEO & Executive Director) to comply with Section 178(1) of Companies Act and Regulation 19(1) of Listing Regulations
  • Committee now consists of three or more non-executive directors with two-thirds independent directors
10. KMP Authorization
  • Authorized Mr. Kaushal Uttam Shah (Managing Director, DIN:02175130) as Key Managerial Personnel
  • For determining materiality of events and making disclosures under Regulation 30 of Listing Regulations
11. Directors' Report
  • Approved Directors' Report for FY ended March 31, 2026
  • Prepared in accordance with Section 134(3) of Companies Act, 2013
12. Management Discussion and Analysis
  • Approved Management Discussion and Analysis Report for FY ended March 31, 2026
  • Prepared in terms of Regulation 34(2)(e) read with Schedule V, Part B of Listing Regulations
13. Director Appointment for SMCV
  • Approved appointment of Mr. Salil Shetty (CEO & Executive Director, DIN:07424136) as Non-Executive Director
  • On Board of SMCV Management Services Private Limited
  • Subject to receipt of consent Form DIR-2 and eligibility declarations
14-15. Director Appointments for Proposed Subsidiary
  • Approved appointment of Mr. Abhiram Ranganath (CFO, DIN:11780518) and Mr. Salil Shetty (CEO & Executive Director, DIN:07424136)
  • As Directors on Board of proposed Wholly Owned Subsidiary
  • Name approval process to be carried out
16. Director Retirement
  • Noted that one director liable to retire by rotation at 41st AGM
  • Mr. Kaushal Uttam Shah identified as director to retire (longest in office among non-independent directors)
  • Eligible for reappointment, offered himself for reappointment
17. Incorporation of Wholly Owned Subsidiary
  • Approved incorporation of new Private Limited Company as Wholly Owned Subsidiary
  • To act as Direct Insurance Brokers in General and Life Insurance
  • As defined under IRDAI (Insurance Brokers) Regulations, 2018
  • Proposal evaluated and recommended by Audit Committee meeting held on August 12, 2026
  • Requires compliance with Section 177 of Companies Act and Regulation 30 of Listing Regulations

Additional Information

  • Company name changed from "Bijoy Hans Limited" to "Arvaya Healthcare Limited" effective May 11, 2026
  • Authorized Share Capital increased from ₹60 crores to ₹200 crores (approved March 17, 2026, shareholders April 19, 2026)
  • Board meeting duration: 4:00 PM to 7:00 PM
  • Financial results reviewed by Khire Khandekar & Kirloskar, Chartered Accountants (FRN: 105148W)
  • Consolidated results include subsidiaries: Arvaya Healthtech and Wellness Private Limited, Tec-pool Solutions Private Limited, Health Secure Hospitals Private Limited, and step-down subsidiary Health Secure Hospital Care & Solution Private Limited